News
12 Health Care Stocks Moving In Friday's After-Market Session
29 Mar 24
Movers
HC Wainwright & Co. Reiterates Buy on VYNE Therapeutics, Maintains $5.75 Price Target
29 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Recap: VYNE Therapeutics Q4 Earnings
29 Feb 24
Earnings
VYNE Therapeutics Q4 Adjusted EPS $(0.18) Beats $(0.50) Estimate, Sales $76.00K Miss $150.00K Estimate
29 Feb 24
Earnings, News
VYNE Therapeutics To Present Results Of Phase 1b Trial For VYN201 At 2024 Global Vitiligo Foundation Annual Scientific Symposium
27 Feb 24
Biotech, News, General